Literature DB >> 4270309

Electrophysiological and histological abnormalities of the heart in myotonic dystrophy.

N Uemura, H Tanaka, T Niimura, N Hashiguchi, M Yoshimura, S Terashi, T Kanehisa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4270309     DOI： 10.1016/0002-8703(73)90338-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  7 in total

1.  Electrocardiographic findings in myotonic dystrophy.

Authors:  B O Olofsson; H Forsberg; S Andersson; P Bjerle; A Henriksson; I Wedin
Journal:  Br Heart J       Date:  1988-01

2.  Primary amyloidosis in a patient with myotonic dystrophy.

Authors:  I G Mackay; D Thomson; A Doig
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-04       Impact factor: 10.154

3.  Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.

Authors:  Guey-Shin Wang; Debra L Kearney; Mariella De Biasi; George Taffet; Thomas A Cooper
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

4.  Myotonia dystrophica with heart involvement: an electron microscopic study of skeletal, cardiac, and smooth muscle.

Authors:  R M Ludatscher; H Kerner; S Amikam; B Gellei
Journal:  J Clin Pathol       Date:  1978-11       Impact factor: 3.411

5.  Reversible cardiac disease features in an inducible CUG repeat RNA-expressing mouse model of myotonic dystrophy.

Authors:  Ashish N Rao; Hannah M Campbell; Xiangnan Guan; Tarah A Word; Xander Ht Wehrens; Zheng Xia; Thomas A Cooper
Journal:  JCI Insight       Date:  2021-03-08

Review 6.  Cardiac Pathology in Myotonic Dystrophy Type 1.

Authors:  Mani S Mahadevan; Ramesh S Yadava; Mahua Mandal
Journal:  Int J Mol Sci       Date:  2021-11-02       Impact factor: 5.923

7.  miR-223-3p and miR-24-3p as novel serum-based biomarkers for myotonic dystrophy type 1.

Authors:  Demetris Koutalianos; Andrie Koutsoulidou; Chrystalla Mytidou; Andrea C Kakouri; Anastasis Oulas; Marios Tomazou; Tassos C Kyriakides; Marianna Prokopi; Konstantinos Kapnisis; Nikoletta Nikolenko; Chris Turner; Anna Lusakowska; Katarzyna Janiszewska; George K Papadimas; Constantinos Papadopoulos; Evangelia Kararizou; George M Spyrou; Geneviève Gourdon; Eleni Zamba Papanicolaou; Grainne Gorman; Andreas Anayiotos; Hanns Lochmüller; Leonidas A Phylactou
Journal:  Mol Ther Methods Clin Dev       Date:  2021-09-14       Impact factor: 6.698
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.